Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties

COSTA, VALERIA DA; MARIÑO, KARINA V.; RODRÍGUEZ-ZRAQUIA, SANTIAGO A.; FESTARI, MARÍA FLORENCIA; LORES, PABLO; COSTA, MONIQUE; LANDEIRA, MERCEDES; RABINOVICH, GABRIEL A.; VAN VLIET, SANDRA J.; FREIRE, TERESA

International Journal of Molecular Sciences

MDPI

Año: 2022 vol. 23

1661-6596

Lung cancer is the first leading cause of cancer-related deaths in the world. Aberrant glycosylation in lung tumors leads to the expression of tumor-associated carbohydrate structures, such as the Tn antigen, consisting of N-acetyl-galactosamine (GalNAc) linked to a serine or threonine residue in proteins (α-GalNAc-O-Ser/Thr). The Tn antigen can be recognized by the Macrophage Galactose/GalNAc lectin (MGL), which mediates various immune regulatory and tolerogenic functions, mainly by reprogramming the maturation of function of dendritic cells (DCs). In this work, we generated two different Tn-expressing variants from the Lewis-type lung murine cancer cell line LL/2, which showed different alterations in the O-glycosylation pathways that influenced the interaction with mouse MGL2 and the immunomodulatory properties of DCs. Thus, the identification of the biological programs triggered by Tn+ cancer cells might contribute to an improved understanding of the molecular mechanisms elicited by MGL-dependent immune regulatory circuits.